Idacio Kit
Product Images NDC 65219-558

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Idacio (NDC 65219-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adali-graph-01.jpg (Adali Graph 01)

A line graph depicting the percent ACR20 responder rates over time in weeks. It compares two groups: one receiving 40 mg every other week and a placebo group. The graph shows percent responder on the Y-axis and time in weeks on the X-axis, illustrating higher response over time for the 40 mg group compared to placebo.*

FDA Label Image

Adali-graph-02.jpg (Adali Graph 02)

A line graph depicting % ASAS 20 Response over Time (Weeks) comparing Adalimumab (N=208) and Placebo (N=107). The x-axis represents time in weeks (0 to 26), and the y-axis represents % ASAS 20 Response (0 to 70%). Adalimumab response increases sharply and plateaus around 50-60%, while placebo shows a lower and fluctuating response up to about 30%.*

FDA Label Image

Adali-graph-03.jpg (Adali Graph 03)

A line graph depicting treatment failure rates over 20 months for two groups: placebo and adalimumab. The y-axis shows treatment failure rate as a percentage, and the x-axis shows time in months. Two lines represent cumulative treatment failure rates, with adalimumab having a lower failure rate than placebo over time.*

FDA Label Image

Adali-graph-04.jpg (Adali Graph 04)

A line graph showing treatment failure rate (%) over time in months for two groups: placebo and adalimumab. The x-axis represents time in months up to 20, and the y-axis shows the treatment failure rate percentage up to 100%. The graph includes lines for placebo and adalimumab treatment groups along with corresponding sample size data below the x-axis.*

FDA Label Image

Adali-img-01.jpg (Adali Img 01)

An instructional illustration showing the components of the IDACIO kit by Fresenius Kabi USA: a vial labeled IDACIO 40 mg, a vial adapter, alcohol prep pads, a needle with a purple and yellow cap, and a syringe in sterile packaging.*

FDA Label Image

Adali-img-02.jpg (Adali Img 02)

An illustration showing hands peeling back a transparent protective cover from a small medical device or component, likely part of the IDACIO (adalimumab-aacf) kit. The device appears clear and purple-tinted, designed for single use or application, consistent with components of a prescription drug kit.*

FDA Label Image

Adali-img-03.jpg (Adali Img 03)

An instructional illustration showing hands manipulating a medical device, likely demonstrating preparation or use of a syringe or injection kit. The image includes a blue downward arrow indicating a step in the process, consistent with instructions for a medication kit.*

FDA Label Image

Adali-img-04.jpg (Adali Img 04)

An instructional illustration showing hands removing a transparent protective cap from a small cylindrical vial or container, highlighted with an inset zoom image for clarity. This visual likely demonstrates proper preparation or handling steps for the drug kit.*

FDA Label Image

Adali-img-05.jpg (Adali Img 05)

An instructional illustration showing hands assembling or preparing a syringe kit, likely related to the IDACIO adalimumab-aacf kit. The image highlights connecting or twisting a component onto the syringe, focusing on a close-up view of the assembly step.*

FDA Label Image

Adali-img-06.jpg (Adali Img 06)

An instructional illustration showing a hand holding a syringe with a plunger being pushed upward by another hand, indicated by a curved blue arrow. The image demonstrates how to operate or prepare the syringe, likely related to the IDACIO kit containing adalimumab-aacf.*

FDA Label Image

Adali-img-07.jpg (Adali Img 07)

Instructional illustration showing a hand holding a syringe, with a close-up inset of the syringe volume markings from 0.1 to 0.5 mL, demonstrating proper measurement and injection technique for a liquid medication.*

FDA Label Image

Adali-img-08.jpg (Adali Img 08)

An instructional illustration showing two hands handling components of a medical kit, likely part of the IDACIO adalimumab-aacf kit. One hand holds a small vial or syringe component above another vial, with a blue spiral arrow indicating a twisting or screwing action to connect or assemble the parts.*

FDA Label Image

Adali-img-09.jpg (Adali Img 09)

An instructional diagram labeling parts of a needle assembly inside outer needle packaging. It identifies the pink needle cover, clear needle cap, textured finger pad, and yellow syringe connector, illustrating the components of a needle used with the IDACIO injection kit.*

FDA Label Image

Adali-img-10.jpg (Adali Img 10)

An illustration showing hands peeling back a protective foil or cover from a small vial or container. The vial contains a liquid and has a colored cap, suggesting preparation for use in a kit format, consistent with the IDACIO adalimumab-aacf kit.*

FDA Label Image

Adali-img-11.jpg (Adali Img 11)

An instructional illustration showing hands handling a syringe with a yellow cap. A blue curved arrow indicates a twisting or rotating motion, suggesting how to properly prepare or unlock the syringe component.*

FDA Label Image

Adali-img-12.jpg (Adali Img 12)

Illustration showing hands preparing a syringe for use, with one hand holding the syringe and the other hand removing a protective cap or packaging. A blue arrow indicates the direction to pull the protective component upwards.*

FDA Label Image

Adali-img-13.jpg (Adali Img 13)

An instructional illustration showing a hand holding a syringe-like pen device, with another hand removing or flipping off a pink protective cap. A blue arrow indicates the motion of removing the cap from the device, demonstrating part of the preparation process for administration.*

FDA Label Image

Adali-img-14.jpg (Adali Img 14)

An instructional illustration showing hands removing the protective cap from a syringe needle, indicated by an upward blue arrow. The syringe has a yellow safety guard over the needle. The image likely demonstrates a preparation step for using an injectable medication.*

FDA Label Image

Adali-img-15.jpg (Adali Img 15)

An instructional illustration depicting how to remove a pink protective cap from a syringe with a yellow needle hub. The steps show a finger gripping the pink cap and pulling it away from the needle, indicated by a blue arrow, to expose the needle for use.*

FDA Label Image

Label-pdpimage (Adali Label 01)

IDACIO 40 mg / 0.8 mL single-dose vial kit for injection containing adalimumab-aacf, labeled for subcutaneous use only. The packaging displays the Fresenius Kabi logo and states it is for institutional use only. The carton lists contents including 1 single-dose vial, 1 sterile syringe, 1 sterile needle, vial adapter, alcohol preps, prescribing information, and medication guide.*

FDA Label Image

Adali-label-02.jpg (Adali Label 02)

Label for IDACIO (adalimumab-aacf) injection, 40 mg per 0.8 mL, intended for subcutaneous use. The label includes a lot number and expiration date fields, a barcode, and states it is a single-dose vial with instructions to discard unused portion. The label shows the US license number and is marked by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.